Cotinga Pharmaceuticals Inc. Stock Toronto S.E.
Equities
COT.H
CA22164W1059
Biotechnology & Medical Research
Sales 2018 | - | Sales 2019 | - | Capitalization | 1.61M 2.22M |
---|---|---|---|---|---|
Net income 2018 | -4M -5.5M | Net income 2019 | -2M -2.75M | EV / Sales 2018 | - |
Net cash position 2018 | 40.73K 56.03K | Net cash position 2019 | 24.64K 33.9K | EV / Sales 2019 | - |
P/E ratio 2018 |
-1.11
x | P/E ratio 2019 |
-0.6
x | Employees | 6 |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 69.18% |
Managers | Title | Age | Since |
---|---|---|---|
Alison D. Silva
PSD | President | 46 | 14-12-31 |
Debi Sanderson
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 17-06-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 18-06-30 | |
John C. Drake
CHM | Chairman | - | 07-02-19 |
Alison D. Silva
PSD | President | 46 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-3.39% | 102B | |
+2.61% | 96.84B | |
-0.70% | 21.48B | |
-18.14% | 20.82B | |
-7.26% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |